ArticleMicrobiologyOpen2026
The Landscape of Salmonella enterica Serovar Gallinarum-Pullorum Antimicrobial Resistance in Bangladesh's Poultry Industry: A Combined Phenotypic and Molecular Study.
Article in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Salmonella enterica serovar Gallinarum-Pullorum is a prevalent poultry-borne pathogen that could facilitate the zoonotic transmission of multidrug-resistant (MDR) strains to humans, significantly contributing to the global burden of antimicrobial resistance (AMR). A total of 200 samples were collected from chickens of various flocks suspected of salmonellosis based on clinical diagnosis and isolation via standard bacteriological protocols, of which 138 tested positive for serovar Gallinarum-Pullorum by polymerase chain reaction (PCR). Each PCR-positive sample's isolates were sent for antimicrobial susceptibility testing, and each PCR-positive sample's DNA samples were sent for PCR-based resistance gene detection to evaluate the effectiveness of antimicrobials, MDR, and AMR status. Isolates were sensitive to gentamicin, amoxicillin-clavulanic acid, and cephalexin at rates of 84.78%, 83.33%, and 81.78%, respectively. Conversely, amoxicillin (71.01% resistant) and tetracycline (73.91% resistant) showed the highest rates of resistance. The MDR group accounted for 123 isolates, translating to a commanding combined prevalence of 89.13%, and resistance peaked at four resistant agents, with an incidence of 31.16% (43). Multiple antibiotic resistance (MAR) Index levels varied from 0.1 to 0.7. AML-SXT-TE-NOR and AML-SXT-TE-NOR-ENR were the most commonly seen patterns, each occurring in five isolates (3.62%). The tetA (74.64%) and the sul1 (73.19%) were the most prevalent resistance genes, with the presence of blaCMY (71.01%), blaTEM (9.42%), blaCTX (7.97%), sul2 (55.80%), dfrA1 (37.68%), aph(3')-IIa (42.03%), aac(3)-VIa (5.80%), aadB (3.62%), floR (35.51%), gyrA (60.87%), and parC (47.83%) genes. This study reveals that S. enterica exhibits high levels of AMR, manifesting in MDR phenotypes supported by a robust presence of resistance-conferring genes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.